NRC: Arsenic in Drinking Water. 1999, Washington, DC: National Academy of Sciences Press
USEPA: National Primary Drinking Water Regulations: Arsenic and clarifications to compliance and new source contaminants monitoring; final rule. Fed Reg. 2001, 66 (no. 14): 6976-7066.
Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH: Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology. 2000, 11: 673-679.
Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR: Arsenic in drinking water and incidence of urinary cancers. Epidemiology. 1997, 8: 545-550.
Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH: Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996, 7: 117-124.
Smith AH, Goycolea M, Haque R, Biggs ML: Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 1998, 147: 660-669.
Steinmaus C, Moore L, Hopenhayn-Rich C, Biggs ML, Smith AH: Arsenic in drinking water and bladder cancer. Cancer Invest. 2000, 18: 174-182.
Tsai S-M, Wang T-N, Ko Y-C: Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health. 1999, 54: 186-193.
Ch'i IC, Blackwell RQ: A controlled retrospective study of blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol. 1968, 88: 7-24.
Engel RR, Smith AH: Arsenic in drinking water and mortality from vascular disease: an ecologic analysis in 30 counties in the United States. Arch Environ Health. 1994, 49: 418-427.
Chen C-J, Chiou H-Y, Chiang M-H, Lin L-J, Tai T-Y: Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscl Throm Vas. 1996, 16: 504-510.
Chiou H-Y, Huang W-I, Su C-L, Chang S-F, Hsu Y-S, Chen C-J: Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke. 1997, 28: 1717-1723.
Rahman M, Tondel M, Ahmad SK, Axelson O: Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol. 1998, 148: 198-203.
Tseng C-H, Tai T-Y, Chong C-K, Tseng C-P, Lai M-S, Lin BJ, Chiou H-Y, Hsueh Y-M, Hsu K-H, Chen C-J: Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: A cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Persp. 2000, 108: 847-851.
Mazumder DNG, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, Sil A, Balmes JR, Haque R, Hira-Smith MM, Smith AH: Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology. 2005, 16: 760-765.
Milton AH, Rahman M: Respiratory effects and arsenic contaminated well water in Bangladesh. Int J Environ Health R. 2002, 12: 175-179.
Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL: Drinking water arsenic in Utah: A cohort mortality study. Environ Health Persp. 1999, 107: 359-365.
Buchet JP, Lison D: Mortality by cancer in groups of the Belgian population with a moderately increased intake of arsenic. Int Arch Occup Environ Health. 1998, 71: 125-130.
Varsanyi I, Fodre Z, Bartha A: Arsenic in drinking water and mortality in the southern Great Plain, Hungary. Environ Geochem Hlth. 1991, 13: 14-22.
Bates MN, Smith AH, Cantor KP: Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol. 1995, 141: 523-530.
Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, Steinmaus C, Smith AH: Case-control study of bladder cancer and exposure to arsenic in drinking water in Argentina. Am J Epidemiol. 2004, 159: 381-389.
Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER: Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol. 2001, 153: 559-565.
Karagas MR, Tosteson TD, Morris JS, Demidenko E, Mott LA, Heaney J, Schned A: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Cause Control. 2004, 15: 465-472.
Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D: Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am J Epidemiol. 2004, 160: 853-859.
Steinmaus C, Yuan Y, Bates MN, Smith AH: Case-control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol. 2003, 158: 1193-1201.
Michigan Department of Public Health: Arsenic in drinking water – A study of exposure and clinical survey. 1982, Division of Environmental Epidemiology, Michigan Department of Public Health, Lansing, MI
Haack SK, Trecanni SL: Arsenic concentration and selected geochemical characteristics for ground water and aquifer materials in southeastern Michigan. 2000, US Geological Survey Water Resources Investigation Report 00-4171
Kim MJ, Nriagu JO, Haack S: Arsenic species and chemistry in groundwater of southeast Michigan. Environ Pollut. 2002, 120: 379-390.
Kolker A, Haack SK, Cannon WF, Westjohn DB, Kim MJ, Nriagu J, Woodruff LG: Arsenic in southeastern Michigan. Arsenic in Ground Water. Edited by: Welch AH, Stollenwerk KG. 2003, Norwell, Massachusetts: Kluwer Academic Publishers, 281-294.
Meliker JR, Slotnick MJ, AvRuskin GA, Kaufmann A, Fedewa SA, Goovaerts P, Jacquez GM, Nriagu JO: Individual lifetime exposure to inorganic arsenic using a Space-Time Information System. Int Arch Occup Environ Health. 2007, 80: 184-197.
Slotnick MJ, Meliker JR, Nriagu JO: Effects of Time and Point-of-Use Devices on Arsenic Levels in Southeastern Michigan Drinking Water, USA. Sci Tot Environ. 2006, 369: 42-50.
Breslow NE, Day NE: Statistical methods in cancer research. Vol II: the design and analysis of cohort studies. 1987, Lyon, France: IARC Scientific publications No. 82
Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY: Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1994, 139: 484-492.
American Diabetics Association: Standards of Medical Care in Diabetes. Diabetic Care. 2005, 28 (Suppl 1): S4-S36.
Anderson RN, Smith BL: Deaths: leading causes for 2002. National Vital Statistics Reports. 2005, 53: 17-
Walton FS, Harmon AW, Paul DS, Drobna Z, Patel YM, Styblo M: Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes. Toxicol Appl Pharmacol. 2004, 198: 424-433.
Salazard B, Bellon L, Jean S, Maraninchi M, El Yazidi C, Orsiere T, Margotat A, Botta A, Bergé-Lefranc J-L: Low-level arsenite activates the transcription of genes involved in adipose differentiation. Cell Biol Toxicol. 2004, 20: 375-385.
Simeonova PP, Luster MI: Arsenic and atherosclerosis. Toxicol Appl Pharmacol. 2004, 198: 444-449.
Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E: Arsenic exposure and cardiovascular disease: a systematic review of the epidemiological evidence. Am J Epidemiol. 2005, 162: 1037-1049.
Blair A, Dosemeci M, Heineman EF: Cancer and other causes of death among male and female farmers from twenty-three states. Am J Ind Med. 1993, 23: 729-742.
Blair A, Sandler DP, Tarone R, Lubin J, Thomas K, Hoppin JA, Samanic C, Coble J, Kamel F, Knott C, Dosemeci M, Zahm SH, Lynch CF, Rothman N, Alavanja MCR: Mortality among participants in the Agricultural Health Study. Ann Epidemiol. 2005, 15: 279-285.
Cerhan JR, Cantor KP, Williamson K, Lynch CF, Torner JC, Burmeister LF: Cancer mortality among Iowa farmers: Recent results, time trends, and lifestyle factors (United States). Cancer Cause Control. 1998, 9: 311-319.
Folsom AR, Zhang S, Sellers TA, Zheng W, Kushi LH, Cerhan JR: Cancer incidence among women living on farms: findings from the Iowa Women's Health Study. J Occup Environ Med. 1996, 38: 1171-1176.
Stiernstrom E, Holmberg S, Thelin A, Svarsudd K: A prospective study of morbidity and mortality rates among farmers and rural and urban nonfarmers. J Clin Epidemiol. 2001, 54: 121-126.
U.S. Department of Health, Education and Welfare: Smoking and Health: A Report of the Surgeon General. 1979, DHEW Publication No. (PHS) 79-50066
Vasiliu O, Cameron L, Gardiner J, DeGuire P, Karmaus W: Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology. 2006, 17: 352-359.
Schillo BA, Skarupski KA, McGee H, Rafferty A: Michigan Risk Factor Surveillance System: Assessing Risk Factors at the Regional Level 1989–1993. 1995, Michigan Dept. of Public Health, Center for Health Promotion and Disease Prevention, Lansing MI
Liu T, Liu J, LeCluyse EL, Zhou YS, Cheng ML, Waalkes MP: Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci. 2001, 59: 185-192.
Paeratakul S, Lovejoy JC, Ryan DH, Bray GA: The relation of gender, race and socioeconomic status to obesity and obesity comorbidities in a sample of US adults. Int J Obesity. 2002, 26: 1205-1210.
Sturm R: The effects of obesity, smoking, and drinking on medical problems and costs. Health Affairs. 2002, 21: 245-253.
Chen CL, Hsu LI, Chiou HY, Hseuh YM, Chen SY, Wu MM, Chen CJ: Ingested arsenic, cigarette smoking, and lung cancer risk. JAMA. 2004, 292: 2984-2290.
NRC: Arsenic in Drinking Water: 2001 Update. 2001, Washington DC: National Academy of Sciences Press
Adami H-O, Hunter D, Trichopoulos D: Textbook of Cancer Epidemiology. 2002, New York: Oxford University Press
Peters SC, Blum JD, Klaue B, Karagas MR: Arsenic occurrence in New Hampshire drinking water. Environ Sci Technol. 1999, 33: 1328-1333.
Morgan CL, Currie CJ, Peters JR: Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2000, 23: 1103-1107.